Local Field Potential Recordings Using Deep Brain Stimulation: A Practical Workflow and Open-Source Signal Processing Pipeline
Clinical Snapshot
PICO Framework
| P — Population | Patients with Parkinson's disease (and implicitly other neurological conditions) who have undergone implantation of deep brain stimulation (DBS) systems with electrophysiological recording capabilities |
| I — Intervention | BrainWave-DBS: an open-source local field potential (LFP) signal processing pipeline encompassing data import, preprocessing, spectral analysis, and visualisation, accompanied by a structured practical workflow guide for LFP acquisition |
| C — Comparator | No formal comparator; the pipeline is demonstrated against a representative Parkinson's disease LFP dataset without head-to-head comparison to existing proprietary or open-source tools |
| O — Outcomes | Feasibility and reproducibility of LFP data acquisition and analysis; demonstration of spectral biomarkers (e.g., beta-band oscillations) relevant to Parkinson's disease; accessibility of the pipeline for broader research adoption; technical insights into signal quality and preprocessing considerations |
Bottom Line
This paper introduces BrainWave-DBS, an open-source pipeline for analysing local field potential (LFP) recordings from implanted DBS systems, accompanied by a structured practical workflow guide. The work addresses a genuine translational bottleneck: while modern sensing-enabled DBS devices (such as the Medtronic Percept PC) can continuously stream subcortical neural signals, most clinical centres lack the analytical infrastructure to convert raw LFP data into meaningful biomarkers. The pipeline covers the full analytical chain from data import through spectral analysis and visualisation, demonstrated using a Parkinson's disease dataset. As a methodological report, it should be evaluated on its utility and reproducibility rather than clinical efficacy. Key limitations include the absence of independent external validation, unclear sample characteristics, no comparative benchmarking against existing tools, and no patient-centred outcomes. For Australian DBS centres, the tool is potentially immediately applicable given TGA approval of compatible sensing-enabled devices, though implementation will require local computational expertise and robust data governance frameworks. This paper is best understood as a foundational infrastructure contribution to the adaptive neuromodulation research ecosystem rather than a clinical evidence paper. Clinicians should regard it as a research enabler, not a practice-changing intervention, pending prospective clinical validation of pipeline-derived biomarkers.
Key Findings
P Value: Not reported — hypothesis testing not performed
Effect Size: Not applicable — no comparative effect size reported; this is a methodological demonstration study
Primary Outcome: Successful demonstration of BrainWave-DBS pipeline functionality for LFP data import, preprocessing, spectral analysis, and visualisation using a representative Parkinson's disease dataset, with identification of key technical insights for LFP acquisition
Nnt Or Sensitivity: Not applicable for this study type; relevant future metrics would include sensitivity/specificity of pipeline-derived beta-band biomarkers for detecting DBS-responsive states in adaptive neuromodulation paradigms
Confidence Interval: Not reported — no inferential statistics presented
Clinical Application
Feasibility for clinical research adoption is moderate-to-high given the open-source availability of BrainWave-DBS. However, practical implementation requires: (1) DBS hardware with LFP streaming capability (not all implanted devices support this); (2) institutional data governance frameworks for handling patient-derived neural data; (3) staff with sufficient neurophysiology and computational literacy to operate and interpret the pipeline; (4) integration with existing clinical workflows without disrupting standard DBS programming appointments. In Australia, DBS for Parkinson's disease is performed at major neurosurgical centres including Royal Melbourne Hospital, Westmead Hospital, Princess Alexandra Hospital, and others. The Medtronic Percept PC — the most widely used sensing-enabled DBS device in Australia — is TGA-approved and supports LFP streaming, making BrainWave-DBS potentially directly applicable. The RACGP and Movement Disorder Society of Australia do not currently have specific guidelines on LFP-guided DBS programming, reflecting the early-stage nature of this technology in routine clinical practice. PBS listing does not cover LFP analysis software, but open-source tools remove this barrier. Australian DBS research groups, including those affiliated with the Bionics Institute and university-based neuroscience centres, may find this pipeline valuable for translational research. Data sovereignty and privacy considerations under the Australian Privacy Act 1988 and state-based health information legislation would need to be addressed before routine clinical implementation. Patients with Parkinson's disease (and potentially other movement disorders, epilepsy, or psychiatric conditions) who have received DBS implants with chronic LFP recording capability. Most immediately applicable to neurophysiology researchers and clinician-scientists at DBS centres seeking to implement structured LFP analysis workflows.
Abstract
Deep brain stimulation (DBS) systems with electrophysiological recording capabilities offer a unique opportunity to chronically record local field potentials (LFP) from implanted electrodes, enabling real-time monitoring of subcortical neural dynamics and the development of adaptive neuromodulation strategies. However, translating raw LFP into clinically relevant biomarkers remains challenging due to numerous technical considerations. To address this, we share both a practical guide for conducting LFP experiments and BrainWave-DBS, an open-source pipeline that implements the workflow and supports analysis of patient-derived LFP data. The pipeline covers data import, preprocessing, spectral analysis, and visualization, offering a reproducible framework for LFP analysis. Furthermore, we demonstrate the functionality of the pipeline using a representative Parkinson's disease dataset and highlight key technical insights gained through this work. By improving access to neural signal acquisition and analysis, our goal is to foster broader adoption of this technology, which could advance closed-loop neuromodulation of deep brain structures.
References
- 1.Guillemette, A., Gobeil, M.-A., Dominguez-Vargas, A.-U., Silhadi, M., Bergeron, D., Vogt, R., Moradi, N., Niazi, F., Weil, A. G., Hadjinicolaou, A., Obaid, S., Assi, E. B., Jodoin, N., Iorio-Morin, C., Dancause, N., & Fournier-Gosselin, M.-P. (2026). Local field potential recordings using deep brain stimulation: A practical workflow and open-source signal processing pipeline. Brain Topography. https://doi.org/10.1002/mds.30076
Related Research
Sleep medicine reviews
Machine and deep learning in REM sleep behavior disorder: a scoping review and analysis of reporting quality
3 Aug 2026
Neurological research
Federated deep learning model for epilepsy seizure detection using electroencephalogram (EEG) signal
2 Aug 2026
Journal of psychiatric research
Systematic review of machine learning and deep learning models for EEG-based detection of depression.
2 Aug 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service